04/11/2024
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
6:02 AM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
3:30 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:14 PM | Zentalis Pharmaceuticals (Filer)
| Form S-3ASR | |
02/29/2024
4:20 PM | Zentalis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:08 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
6:43 PM | Avidity Partners Management LP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
7:21 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:22 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:23 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:40 AM | WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/05/2024
6:11 PM | Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:12 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:13 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:14 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:15 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:16 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:26 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:27 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:28 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:26 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:52 AM | STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:19 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
7:21 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:47 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:24 PM | Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:24 PM | Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
8:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
8:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023
2:40 PM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G | |
10/06/2023
6:18 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
6:19 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
10/06/2023
6:19 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
4:00 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:25 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2023
7:26 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2023
7:28 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:11 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
3:09 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
6:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2023
3:30 PM | Matrix Capital Management Company, LP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13D/A | |
06/20/2023
3:30 PM | GOEL DAVID E. (Reporting)
Matrix Capital Management Company, LP (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:19 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:01 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:02 PM | Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:04 PM | Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:23 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
3:12 PM | Zentalis Pharmaceuticals (Filer)
| Form 424B5 | |
06/15/2023
6:03 AM | Zentalis Pharmaceuticals (Subject)
| Form FWP | |
06/15/2023
5:02 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
8:10 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
1:24 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
8:37 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2023
8:09 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
8:10 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
3:34 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/26/2023
11:38 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
6:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
6:08 AM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
05/10/2023
6:11 AM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/10/2023
6:13 AM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
